Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All”

Jim Cramer gave top insight on Tempus AI, Inc. (NYSE:TEM), sharing a game plan of what to buy, sell, and hold right now. During the lightning round, a caller inquired if there is any future for the stock, and here’s what Cramer had to say in response:

I like this stock, but the problem is it’s a high multiple stock in a sell-off that is driven in part by oil and in part by interest rates. It will keep going lower. It’s a decent spec. I would hold on to some, but not all.

Photo by Artem Podrez on Pexels

Tempus AI, Inc. (NASDAQ:TEM) develops technology that organizes and analyzes large amounts of clinical and molecular data to help doctors personalize patient care. The company’s platform uses AI to run diagnostic tests, match patients with clinical trials, and assist pharmaceutical companies in discovering new cancer treatments. During the February 6 episode, a caller asked whether the stock was a buy, sell, or hold, and Cramer responded:

Well, you know we’re not recommending stocks that are losing a lot of money here just because the year of magical investing made a return, and I think that you got a little reprieve, and it’s going to go back down again.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.